Popular weight loss drugs linked to rare but severe stomach ... - NBC News
People who take popular drugs for weight loss, like Ozempic or Wegovy, may be at an increased risk of severe stomach issues, research published Thursday finds.
What the results of Wegovy’s longest clinical trial yet show about ...
May 13, 2024 · New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight loss and...
New study focuses on what happens if you stay on weight loss …
May 20, 2024 · Now, a new study released earlier this month by Novo Nordisk, the maker of both Ozempic and Wegovy, is shedding light on what the long-term results look like for people on the weight loss medications.
West Virginia patients are left in limbo over changing insurance ...
Jan 2, 2025 · CHARLESTON, W.Va. (AP) — Lory Osborn says the Wegovy she was prescribed 15 months ago did more than help her lose 75 pounds — over a quarter of her body weight. The administrative assistant at West Virginia University said she feels healthier at 62 than she has since graduating high school.
Zepbound sheds more weight than Wegovy in trial, Eli Lilly says - NBC News
Dec 4, 2024 · People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a head-to-head clinical trial, Lilly said in a news release Wednesday.
Wegovy users keep weight off for 4 years, new analysis finds - NBC News
May 14, 2024 · Patients taking Novo Nordisk’s Wegovy obesity treatment maintained an average of 10% weight loss after four years, potentially boosting the drugmaker’s case to insurers and governments to...
Results of Wegovy's longest clinical trial on weight loss ... - CTV News
May 14, 2024 · New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight loss and how safe...
Wegovy patients maintained weight loss for 4 years, analysis shows
May 20, 2024 · Now, a new study published May 13 in Nature medicine affirms that Wegovy remains effective for losing weight and maintaining weight loss for at least four years, doubling the previous estimate....
Wegovy is a weight-loss drug. Health Canada says it can now be …
Nov 27, 2024 · Novo Nordisk said Wednesday that Wegovy is the first Health Canada-approved treatment for both chronic weight management and to reduce the risk of non-fatal myocardial infarction.
Lilly's Zepbound® (tirzepatide) superior to Wegovy® …
Dec 4, 2024 · On average, Zepbound led to a superior weight loss of 20.2% compared to 13.7% with Wegovy. i At 72 weeks, Zepbound beat Wegovy on both the primary endpoint and all five key secondary endpoints in this trial of adults living with obesity or overweight with at least one weight-related medical problem and without diabetes.